Are we moving towards a new definition of essential medicines?
- 1*
- 1Department of Pharmacology, Weill Cornell Medical College, New York, USA.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Marcus M. Reidenberg
Department of Pharmacology, Weill Cornell Medical College, New York, USA.
Email: mmreid@med.cornell.edu
Copyright: © 2015 The Author(s). This is an open access article.
Published: Jan 1, 2015, Received: Sep 30, 2015, Accepted: Oct 16, 2015
Abstract
The problems of health care in 1977 when the definition of an essential medicine was written were different than those of 2015. Then the focus was on helping developing countries improve the inadequate health care available for many people in these countries.[2] Infectious disease was upmost in people’s minds. Thirty‑nine anti‑infective drugs were in the main list then, along with seven antineoplastic drugs. Around 1990, some middle‑income countries desired advice about cancer medicines. A World Health Organization (WHO) consultation was held and divided cancer medicines into three categories: Drugs that significantly prolonged survival, those that improved quality of life, and those that did neither.[3] An expert committee decided that those in the first two categories were essential. It appears that this determination that drugs in these two categories are essential continues to the present.
Keywords
Subject
Recommended articles
- Randomized controlled comparison of agomelatine and escitalopram: Concerns about study design and methods
Sutanaya Pal, Ekta Franscina Pinto, Nitin B. Raut · Journal of Pharmacology and Pharmacotherapeutics
- Effect of losartan and atenolol on insulin sensitivity in nondiabetic hypertensive patients
K. B. Rakesh, Sheetal D. Ullal, B. Sunil Pai · Journal of Pharmacology and Pharmacotherapeutics
- Prescription errors in cancer chemotherapy: Omissions supersede potentially harmful errors
Subodh Kumar · Journal of Pharmacology and Pharmacotherapeutics
- VACCRaksha Calc: A computer program for the calculation of vaccine potency
D = log10 of the dilution factor · Journal of Pharmacology and Pharmacotherapeutics
- Author reply
Sangeeta Bhanwra, Kaza Ahluwalia · Journal of Pharmacology and Pharmacotherapeutics
- Drug utilization pattern and pharmacoeconomic analysis in geriatric medical in-patients of a tertiary care hospital of India
Viral N. Shah · Journal of Pharmacology and Pharmacotherapeutics
Readers Also Viewed
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026
Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia
Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby
Jan 1, 2026